Financial News
Latest News about UTHR
Recent news which mentions UTHR
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
From Benzinga
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
January 12, 2021
From Benzinga
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
January 08, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 07, 2021
From Benzinga
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
January 07, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
January 05, 2021
From Benzinga
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
January 05, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Monday
January 04, 2021
From Benzinga
The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data
December 30, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 29, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 24, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 18, 2020
From Benzinga
The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
December 17, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 16, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 14, 2020
From Benzinga
The Daily Biotech Pulse: Roche & Moderna Strike COVID Testing Partnership, Rocket Pharma's Gene Therapy Readout, Breast Cancer Presentations
December 09, 2020
From Benzinga
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger
November 20, 2020
From Benzinga
The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration
November 17, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
November 16, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
November 04, 2020
From Benzinga
The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings
November 04, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
November 03, 2020
From Benzinga
The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure
November 03, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
November 02, 2020
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts
October 30, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
October 29, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.